These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15590879)
21. The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Bowen SE; Batis JC; Paez-Martinez N; Cruz SL Neurotoxicol Teratol; 2006; 28(6):636-47. PubMed ID: 17064879 [TBL] [Abstract][Full Text] [Related]
23. Dextromethorphan-induced neurologic illness in a patient with negative toxicology findings. Cherkes JK; Friedman JH Neurology; 2006 Jun; 66(12):1952-3. PubMed ID: 16801672 [No Abstract] [Full Text] [Related]
24. Psychiatric patients in the pediatric emergency department undergoing routine urine toxicology screens for medical clearance: results and use. Fortu JM; Kim IK; Cooper A; Condra C; Lorenz DJ; Pierce MC Pediatr Emerg Care; 2009 Jun; 25(6):387-92. PubMed ID: 19458561 [TBL] [Abstract][Full Text] [Related]
25. Reversible Ethyl Chloride Neurotoxicity: A Case Report. Al-Ajmi AM; Morad MA; Cooper PE; Hassino LH; Siddeiq MA Can J Neurol Sci; 2018 Jan; 45(1):119-120. PubMed ID: 29157319 [No Abstract] [Full Text] [Related]
26. Recognizing Ethyl Chloride Neurotoxicity: Inhalant Abuse Hidden in Plain Sight. Young R; Carter C; Cardinali S; Khan Z; Bennett K; Jarosz A; Sobecki J; Sharma R; Martin R Cureus; 2023 Apr; 15(4):e37795. PubMed ID: 37214062 [TBL] [Abstract][Full Text] [Related]
31. Abuse of ethyl chloride. Hersh R Am J Psychiatry; 1991 Feb; 148(2):270-1. PubMed ID: 1670982 [No Abstract] [Full Text] [Related]
32. High prevalence of substance use disorders among adolescents who use marijuana and inhalants. Wu LT; Pilowsky DJ; Schlenger WE Drug Alcohol Depend; 2005 Apr; 78(1):23-32. PubMed ID: 15769554 [TBL] [Abstract][Full Text] [Related]
33. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection. Paredes AH; Lewis JH Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078 [TBL] [Abstract][Full Text] [Related]
34. Inhalant abuse in New Zealand. Beasley M; Frampton L; Fountain J N Z Med J; 2006 May; 119(1233):U1952. PubMed ID: 16680169 [TBL] [Abstract][Full Text] [Related]
35. Organic solvent and aerosol abuse. Miller NS; Gold MS Am Fam Physician; 1991 Jul; 44(1):183-9. PubMed ID: 2058531 [TBL] [Abstract][Full Text] [Related]
36. Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation. Gareri P; De Fazio P; Gallelli L; De Fazio S; Davoli A; Seminara G; Cotroneo A; De Sarro G Ann Pharmacother; 2008 Mar; 42(3):434-8. PubMed ID: 18303146 [TBL] [Abstract][Full Text] [Related]
38. Progressive tremor, truncal ataxia, and acute mental status changes after use of bupropion. Li L; Rozolsky DM; Walke L; Jeffery SM Consult Pharm; 2011 Sep; 26(9):665-71. PubMed ID: 21896473 [TBL] [Abstract][Full Text] [Related]
39. The latest evidence in the neuroscience of solvent misuse: an article written for service providers. Cruz SL Subst Use Misuse; 2011; 46 Suppl 1():62-7. PubMed ID: 21609148 [TBL] [Abstract][Full Text] [Related]
40. Rosenthal fiber encephalopathy presenting with demyelination and Rosenthal fibers in a solvent abuser: adult Alexander's disease? Wilson SP; Al-Sarraj S; Bridges LR Clin Neuropathol; 1996; 15(1):13-6. PubMed ID: 8998849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]